<p>To provide a novel compound or an isotope thereof or a pharmaceutically acceptable salt thereof having S1P lyase inhibitory capacity and inducing the decrease in number of lymphocytes, and a pharmaceutical composition containing these as active ingredients. A compound represented by the general formula (I):
, or the general formula (II):
or an isotope thereof or a pharmaceutically acceptable salt thereof.</p>
申请公布号
EP2537831(B1)
申请公布日期
2014.12.03
申请号
EP20110744690
申请日期
2011.02.17
申请人
DAIICHI SANKYO COMPANY, LIMITED
发明人
MACHINAGA, NOBUO;CHIBA, JUN;MURO, FUMIHITO;YUITA, HIROSHI;WATANABE, JUN
